The pharmaceutical packaging market is projected to reach USD 364.11 billion by 2030 from USD 174.85 billion in 2025, at a CAGR of 15.8% during the forecast period. The reports 2025 research report offers an analytical view of the industry by studying different factors like pharmaceutical packaging market growth, consumption volume, Market Size, Revenue, Market Share, Market Trends, and industry cost structures during the forecast period from 2025 to 2030.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=890
The pharmaceutical packaging market across primary and secondary applications has experienced substantial growth, primarily because safety, efficacy, and compliance requirements are becoming increasingly stringent across oral, injectable, and topical drug delivery formats. The growing global demand for patient-friendly, tamper-evident, and sustainable packaging means we have to develop new packaging options that protect integrity, stability, and dosages while also maintaining compliance with regulatory expectations, and the trends are shifting toward new drug formulations and personalized medicine. Commonly used products such as plastic bottles, blister packs, prefillable syringes, vials, and tubes are designed to deliver some of the most critical and sought-after performance attributes, including barrier protection, sterility, ease of use, and extended shelf life in challenging storage and transportation conditions. A key market driver is the emphasis on recyclable and sustainable packaging systems backed by regulatory authorities and the pharmaceutical sector’s focus on achieving carbon-neutral and circular economy initiatives. Further, advancements in smart packaging technologies, including RFID-enabled tracking, digital dose reminders, and connected care devices, offer patient adherence, supply chain transparency, and reduced medicine waste. This illustrates that pharmaceutical packaging is extending beyond compliance and protection to consider innovation, safety of patients, and sustainability in worldwide health care markets.
Plastic bottles are set to form the largest segment by type during the forecast period
Plastic bottles are the largest segment by type during the forecast period. Plastic bottles are expected to remain the largest segment in the pharmaceutical packaging market in terms of value during the forecast period. Their dominance is supported by wide applications in packaging tablets, capsules, oral liquids, and OTC medicines. Plastic bottles have many benefits, including their lightweight nature, durability, cost-effectiveness, and versatility in design. The increasing incorporation of child-resistant and tamper-evident closures offers increased patient safety and regulatory compliance, helping to drive plastic bottle demand. New formulations of resin and barrier technologies are improving moisture and oxygen resistance with plastic bottles, allowing them to be used in more sensitive pharmaceutical formulations as well. With the development of sustainable and recyclable plastics, plastic bottles can remain the primary choice in global pharmaceutical packaging.
Primary packaging is estimated to be the largest segment by packaging type during the forecast period
In the pharmaceutical packaging sector, primary packaging commands the largest share. Primary packaging primarily functions to protect drug formulations from various threats while maintaining sterility, stability, and a drug product’s suitability for patient use. This section mainly comprises formats, including vials, blister packs, ampoules, and prefillable syringes. The growth in biologics, vaccines, and injectable therapies is also increasing the demand for new sterile primary packaging formats on the market. For example, regulations to protect patients from harm, and to track and report changes to the drug product, implementing design features to provide added protection against counterfeiting, and shelf life extensions of drug products will help support the primary packaging segment of the pharmaceutical packaging market. As part of this, the advancement of smart primary packaging and technology, such as digital smart blister packs for monitoring adherence, and RFID-enabled vials, demonstrates that innovation is extending the function of primary packaging beyond maintaining containment and better informing the market that smart primary packaging is on the rise.
Get a Sample Copy of This Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=890
Plastic is projected to be the most in-demand material for pharmaceutical packaging during the forecast period
In terms of value, plastics continue to dominate the pharmaceutical packaging market in terms of raw materials. Their multifunctionality in different packaging formats, bottles, blisters, caps, closures, and flexible films makes them an invaluable resource in the industry. Plastic is also exceptionally flexible, lightweight, reasonably priced, and safer than alternatives compared to other types of containers. Continuing to evolve with new grades of plastics—cyclic olefin polymers (COP) and cyclic olefin copolymers (COC) designed for injectable drug packaging—expands their use in the high-cost setting. Moreover, the increased regulatory scrutiny on sustainability is pushing packaging manufacturers to use recyclables and bio-based plastics, which reinforces plastics’ continued leadership in the pharmaceutical packaging market.
North America is projected to be the largest segment by region during the forecast period
During the forecast period, North America is projected to have the largest market share of pharmaceutical packaging in terms of value. North America’s leading position is supported by a large and aging population, an increasing prevalence of chronic diseases such as Alzheimer’s, diabetes, and cardiovascular diseases, and high per capita healthcare spending in the region. The US remains the primary driver of demand, with strong domestic pharmaceutical production and continuous investments in advanced packaging technologies, particularly for biologics and specialty drugs. Packaging companies will be regulated on safety, sterility, and sustainability by many agencies, such as the FDA and USP, requiring these companies to be creative. North America continues to be a leader in adopting digital-enabled packaging technologies, such as serialization and track-and-trace systems, as required under the Drug Supply Chain Security Act (DSCSA).
Pharmaceutical Packaging Companies
The report profiles key companies, including Amcor Plc (Switzerland), Gerresheimer AG (Germany), Schott AG (Germany), AptarGroup, Inc. (US), and BD (US), which are some major players in the pharmaceutical packaging market. These players have adopted various strategies such as mergers & acquisitions, joint ventures, and expansion to strengthen their market position.
Amcor plc is a leading packaging company for food, beverage, pharmaceutical, medical, home & personal care, and other products. It is primarily involved in the manufacturing and marketing of flexible packaging, rigid containers, and specialty cartons and closures by using raw materials such as polymers, aluminum foils, and fibers. Amcor plc operates a substantial global network of manufacturing and support facilities across its two main segments: Flexibles and Rigid Packaging. The Flexibles segment comprises 160 significant facilities spanning 36 countries, of which 111 are directly owned by the company and 49 are leased from external parties.
Inquire Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=890
Gerresheimer AG is a recognized leader in the global marketplace for pharmaceutical packaging, drug delivery devices, and integrated healthcare solutions, serving pharmaceutical and biotechnology customers throughout the world. Gerresheimer develops and supplies primary packaging solutions made from glass and plastic for medicines, diagnostics, and healthcare applications. Gerresheimer has three operating segments: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies, with pharmaceutical packaging mainly within the Plastics & Devices and Primary Packaging Glass segments.
Schott AG manufactures high-tech materials for specialty glasses. The company operates as a subsidiary of Carl-Zeiss-Stiftung (Germany). It operates through precision materials, optical industries, home appliances, and trade & others. The packaging business is conducted through its precision materials business division. Schott AG serves numerous industries, including healthcare, home appliances & living, consumer electronics, semiconductors & datacom, optics, industry & energy, automotive, and astronomy & aerospace. Schott established its subsidiary, Schott Pharma, to advance its growth strategy for its pharma business, particularly in drug containment and delivery solutions.
AptarGroup, Inc. is a leading manufacturer of sealing, packaging, and innovative dispensing solutions. It operates through beauty & home, pharma, and food & beverage business segments. The pharmaceutical packaging business is a part of its pharma business segment and has four divisions: prescription drug, consumer health care, injectables, and active packaging.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-packaging-market-890.html